Evidence map›Paper›PMID 29191837›Full record

ArticleThe Journal of biological chemistry2018

Age-dependent increase in angiopoietin-like protein 2 accelerates skeletal muscle loss in mice.

Jiabin Zhao, Zhe Tian, Tsuyoshi Kadomatsu, Peiyu Xie, Keishi Miyata, Taichi Sugizaki, Motoyoshi Endo, Shunshun Zhu, Haoqiu Fan, Haruki Horiguchi and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Mouse models of sarcopenia: classification and evaluation.Journal of cachexia, sarcopenia and muscle · 2021
    Review
  10. AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Cellular and molecular mechanisms of sarcopenia: the S100B perspective.Journal of cachexia, sarcopenia and muscle · 2018
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Jiabin ZhaoFrom the Departments of Molecular Genetics.
Zhe TianFrom the Departments of Molecular Genetics, zhetian0118@gmail.com.
Tsuyoshi KadomatsuFrom the Departments of Molecular Genetics.
Peiyu XieFrom the Departments of Molecular Genetics.
Keishi MiyataFrom the Departments of Molecular Genetics.
Taichi SugizakiFrom the Departments of Molecular Genetics.
Motoyoshi EndoFrom the Departments of Molecular Genetics.
Shunshun ZhuFrom the Departments of Molecular Genetics.
Haoqiu FanFrom the Departments of Molecular Genetics.
Haruki HoriguchiFrom the Departments of Molecular Genetics.
Jun MorinagaFrom the Departments of Molecular Genetics.
Kazutoyo TeradaFrom the Departments of Molecular Genetics.
Tatsuya YoshizawaMedical Biochemistry, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Kazuya YamagataMedical Biochemistry, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Yuichi OikeFrom the Departments of Molecular Genetics, oike@gpo.kumamoto-u.ac.jp.
Kumamoto University · JPLaboratory of Molecular Genetics · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle atrophy, or sarcopenia, is commonly observed in older individuals and in those with chronic disease and is associated with decreased quality of life. There is recent medical and broad concern that sarcopenia is rapidly increasing worldwide as populations age. At present, strength training is the only effective intervention for preventing sarcopenia development, but it is not known how this exercise regimen counteracts this condition. Here, we report that expression of the inflammatory mediator angiopoietin-like protein 2 (ANGPTL2) increases in skeletal muscle of aging mice. Moreover, in addition to exhibiting increased inflammation and accumulation of reactive oxygen species (ROS), denervated atrophic skeletal muscles in a mouse model of denervation-induced muscle atrophy had increased ANGPTL2 expression. Interestingly, mice with a skeletal myocyte-specific

Indexed as

Up-RegulationAgingAngiopoietin-Like Protein 2Angiopoietin-like ProteinsAnimalsFemaleMaleMiceMice, KnockoutMuscle Fibers, SkeletalMuscle, SkeletalPhysical Conditioning, AnimalSarcopeniaAngiopoietin-Like Protein 2Angiopoietin-like ProteinsAngptl2 protein, mouseagingANGPTL2catalaseexerciseinflammationmuscle atrophyreactive oxygen species (ROS)sarcopeniasatellite cellsenescence

Identifiers

PMID29191837
PMCPMC5798292
OpenAlexW2773573021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.